Home
>
National Drug Code (NDC)
>
Clindamycin Phosphate
Clindamycin Phosphate - 51672-4081-3 - (Clindamycin phosphate)
Drug Information of Clindamycin Phosphate
| Product NDC: | 51672-4081 |
| Proprietary Name: | Clindamycin Phosphate |
| Non Proprietary Name: | Clindamycin phosphate |
| Active Ingredient(s): | 10 mg/mL & nbsp; Clindamycin phosphate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindamycin Phosphate
| Product NDC: | 51672-4081 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065184 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040331 |
Package Information of Clindamycin Phosphate
| Package NDC: | 51672-4081-3 |
| Package Description: | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (51672-4081-3) > 30 mL in 1 BOTTLE, WITH APPLICATOR |
NDC Information of Clindamycin Phosphate
| NDC Code | 51672-4081-3 |
| Proprietary Name | Clindamycin Phosphate |
| Package Description | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (51672-4081-3) > 30 mL in 1 BOTTLE, WITH APPLICATOR |
| Product NDC | 51672-4081 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin phosphate |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20040331 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
